These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35076049)

  • 1. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
    Kamaly N; Farokhzad OC; Corbo C
    Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions.
    Qin M; Zhang J; Li M; Yang D; Liu D; Song S; Fu J; Zhang H; Dai W; Wang X; Wang Y; He B; Zhang Q
    Theranostics; 2020; 10(3):1213-1229. PubMed ID: 31938061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of protein corona on the biological behavior of targeting nanomedicines.
    Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
    Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities.
    Salvati A
    Curr Opin Biotechnol; 2024 Jun; 87():103101. PubMed ID: 38461749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
    Song D; Xu Q
    Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to effectively prepare a sample for bottom-up proteomic analysis of nanoparticle protein corona? A critical review.
    Kruszewska J; Zajda J; Matczuk M
    Talanta; 2021 May; 226():122153. PubMed ID: 33676702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design.
    Liu K; Salvati A; Sabirsh A
    Nanoscale; 2022 Feb; 14(6):2136-2154. PubMed ID: 35103268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein bio-corona: critical issue in immune nanotoxicology.
    Neagu M; Piperigkou Z; Karamanou K; Engin AB; Docea AO; Constantin C; Negrei C; Nikitovic D; Tsatsakis A
    Arch Toxicol; 2017 Mar; 91(3):1031-1048. PubMed ID: 27438349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery.
    Trinh DN; Gardner RA; Franciosi AN; McCarthy C; Keane MP; Soliman MG; O'Donnell JS; Meleady P; Spencer DIR; Monopoli MP
    ACS Nano; 2022 Apr; 16(4):5463-5475. PubMed ID: 35341249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions.
    Kokkinopoulou M; Simon J; Landfester K; Mailänder V; Lieberwirth I
    Nanoscale; 2017 Jun; 9(25):8858-8870. PubMed ID: 28632260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes.
    Ferdosi S; Stukalov A; Hasan M; Tangeysh B; Brown TR; Wang T; Elgierari EM; Zhao X; Huang Y; Alavi A; Lee-McMullen B; Chu J; Figa M; Tao W; Wang J; Goldberg M; O'Brien ES; Xia H; Stolarczyk C; Weissleder R; Farias V; Batzoglou S; Siddiqui A; Farokhzad OC; Hornburg D
    Adv Mater; 2022 Nov; 34(44):e2206008. PubMed ID: 35986672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration and composition of the protein corona as a function of incubation time and serum concentration: an automated approach to the protein corona.
    Poulsen KM; Payne CK
    Anal Bioanal Chem; 2022 Oct; 414(24):7265-7275. PubMed ID: 36018335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-nanoparticle interactions and a new insight.
    Ghosh G; Panicker L
    Soft Matter; 2021 Apr; 17(14):3855-3875. PubMed ID: 33885450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.